Literature DB >> 5774074

New drug for leprosy.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5774074      PMCID： PMC1982478     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  SULPHONE RESISTANCE IN LEPROSY. AN EXPERIMENTAL AND CLINICAL STUDY.

Authors:  J H PETTIT; R J REES
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

2.  RED AND BLACK PIGMENTATION DEVELOPING DURING TREATMENT OF LEPROSY WITH 'B 663'.

Authors:  S G BROWNE
Journal:  Lepr Rev       Date:  1965-01       Impact factor: 0.537

3.  "B 663" in the treatment of leprosy. Preliminary report of a pilot trial.

Authors:  S G BROWNE; L M HOGERZEIL
Journal:  Lepr Rev       Date:  1962-01       Impact factor: 0.537

4.  Some recent chemotherapeutic work in leprosy: with a discussion of some of the problems involved in clinical trials.

Authors:  T F DAVEY
Journal:  Trans R Soc Trop Med Hyg       Date:  1960-05       Impact factor: 2.184

5.  A new series of phenazines (rimino-compounds) with high antituberculosis activity.

Authors:  V C BARRY; J G BELTON; M L CONALTY; J M DENNENY; D W EDWARD; J F O'SULLIVAN; D TWOMEY; F WINDER
Journal:  Nature       Date:  1957-05-18       Impact factor: 49.962

6.  A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663).

Authors:  F M Imkamp
Journal:  Lepr Rev       Date:  1968-07       Impact factor: 0.537

7.  Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.

Authors:  J H Pettit; R J Rees; D S Ridley
Journal:  Int J Lepr Other Mycobact Dis       Date:  1967 Jan-Mar

8.  Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.

Authors:  T W Williams; P D Mott; P T Wertlake; J B Rubio; R C Adler; G J Hill; G P Suarez; V Knight
Journal:  Int J Lepr       Date:  1965 Jul-Sep

9.  Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).

Authors:  J H Pettit; R J Rees
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Oct-Dec
  9 in total
  1 in total

Review 1.  Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche.

Authors:  Sarah A McGuffin; Paul S Pottinger; James P Harnisch
Journal:  Open Forum Infect Dis       Date:  2017-07-20       Impact factor: 3.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.